Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Autor: Wieske, L., Stalman, E.W., Dam, P.J.K. van, Kummer, L.Y., Steenhuis, M., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G., Kooi, A. van der, Raaphorst, J., Lowenberg, M., Takkenberg, B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, Y.K.O., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Keijzer, S., Keijser, J., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Ham, S.M. van, Kuijpers, T.W., Rispens, T., Eftimov, F., T2B Immunity SARS CoV 2 Study Grp

Publikováno v: Annals of the Rheumatic Diseases, 82(6). BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(6):ard-2022-223464, 883-885. BMJ Publishing Group
Wieske, L, Stalman, E W, van Dam, P J K, Kummer, L Y, Steenhuis, M, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G, van der Kooi, A, Raaphorst, J, Löwenberg, M, Takkenberg, B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, Y K O, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D, Schreurs, C R G, van der Pol, W L, Goedee, H S, Keijzer, S, Keijser, J, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, van Ham, S M, Kuijpers, T W, Rispens, T & Eftimov, F 2023, ' Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 82, no. 6, ard-2022-223464, pp. 883-885 . https://doi.org/10.1136/ard-2022-223464

Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial humoral responses after SARS-CoV-2 vaccination depending on the type of immunosuppression (ISP) used.1 It is largely unknown how antibody titres develop over time a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99222bd4480c23f593e485025fad7855
https://cris.maastrichtuniversity.nl/en/publications/37914ba7-448c-444b-98a0-1064dafade94

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Autor: Stalman, E.W., Wieske, L., Dam, K.P.J. van, Kummer, L.Y., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G.J., Kooi, A.J. van der, Raaphorst, J., Lowenberg, M., Takkenberg, R.B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A.E., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, O.Y.K., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D.J., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Steenhuis, M., Keijzer, S., Keijser, J.B.D., Boogaard, A., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Rispens, T., Ham, S.M. van, Kuijpers, T.W., Eftimov, F., T2B Immunity Against SARS Co

Publikováno v: Annals of the Rheumatic Diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the rheumatic diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the Rheumatic Diseases, 81, 1757-1766. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81(12), 1757-1766. BMJ Publishing Group
Stalman, E W, Wieske, L, van Dam, K P J, Kummer, L Y, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G J, van der Kooi, A J, Raaphorst, J, Löwenberg, M, Takkenberg, R B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A E, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, O Y K, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D J, Schreurs, C R G, van der Pol, W L, Goedee, H S, Steenhuis, M, Keijzer, S, Keijser, J B D, Boogaard, A, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, Rispens, T, van Ham, S M, Kuijpers, T W & Eftimov, F 2022, ' Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 12, 222904, pp. 1757-1766 . https://doi.org/10.1136/ard-2022-222904
Annals of the Rheumatic Diseases, 81(12). BMJ PUBLISHING GROUP

ObjectivesTo compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron breakthrough infections between patients with immune-mediated inflammatory diseases (IMID) on immunosuppressants and controls, and to investigate determ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19dc8c343aa3a7c58690faa029528df1
https://pure.eur.nl/en/publications/95be4c3a-8d51-4bec-a116-f9d40c9a985a

Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study

Autor: Volkers, A., Wieske, L., van Dam, K., Steenhuis, M., Stalman, E., Kummer, L., van Kempen, Z., Killestein, J., Tas, S., Boekel, L., Wolbink, G., Takkenberg, B., Spuls, P., Bosma, A., Rutgers, B., Verschuuren, J., van Ouwerkerk, L., van der Woude, D., van Paassen, P., Busch, M., Brusse, E., Hijnen, D., ten Brinke, A., Verstegen, N., D'Haens, G., van Ham, M., Kuijpers, T., Rispens, T., Lowenberg, M., Eftimov, F.

Publikováno v: Journal of Crohn's and Colitis, 16, I079-I079. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::0a5f11c97719254ed52f2c66f24eeaa1
https://pure.eur.nl/en/publications/9268c1bc-95d8-4fac-927a-3a6b7709f569

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.